Skip to main content
MGRX
NASDAQ Industrial Applications And Services

Mangoceuticals Clears Path for Up to $10M Series D Preferred Offering

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.19
Mkt Cap
$4.332M
52W Low
$0.162
52W High
$2.41
52W Position info
17% above low
Off High info
92% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

MGRX sits 17% above its 52-week low of $0.162 on light trading volume (0.2× avg).

Summary

Mangoceuticals' sole Series B preferred holder approved a new 8% Series D convertible preferred, clearing the way for a Regulation A offering of up to 1,000,000 shares at $10.00 each, or up to $10,000,000. The designation is not yet filed or effective, and the company may not proceed.


Key Events · Financing and Capital Events · MGRX

  • Series D Preferred Approved by Sole B Holder

    On November 2, 2026, the holder of all 50 Series B preferred shares consented in writing to the Series D designation and to a Series B amendment that subordinates existing dividend and liquidation rights.

  • Up to $10M Regulation A Offering Contemplated

    Under Regulation A, the company may sell up to 1,000,000 Series D shares at $10.00 per share, or up to $10,000,000, in one or more transactions.

  • Nothing Filed or Effective Yet

    Neither the Series B Amendment nor the Series D Designation has been filed with the Texas Secretary of State; no sales can occur before the SEC qualifies a Form 1-A offering statement, and the company may abandon the offering.

  • Combined Annual Meeting Set for December 30

    The combined 2025 and 2026 annual meeting will be held December 30, 2026, with a November 12, 2026 record date and a November 16, 2026 deadline for shareholder proposals and director nominations.


Analysis · MGRX · Industrial Applications And Services

A single holder of all 50 Series B preferred shares has signed off on a new 8% Series D convertible preferred that would rank ahead of the existing Series B on dividends and liquidation. Through a Regulation A offering, the company is authorized to sell up to 1,000,000 Series D shares at $10.00 each, or up to $10,000,000 — roughly 23x the company's current market value, making the raise transformative if completed. Nothing is effective yet: the designation has not been filed with Texas, no Form 1-A has been qualified, and management can walk away. For a company that previously disclosed a going-concern warning and Nasdaq delisting risk, this is the latest in a string of small raises and asset sales, and the senior ranking means common holders sit further back in the capital stack.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MGRX was trading at $0.19 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.3M. The 52-week trading range was $0.16 to $2.41. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MGRX - Latest Insights

MGRX
Nov 16, 2026, 5:25 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.1615
Real-time Price: $0.124 info
Change: -$0.0375 (-23%) info
Market Cap: $2.747M info
MGRX
Nov 13, 2026, 5:25 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.155
Real-time Price: $0.124 info
Change: -$0.031 (-20%) info
Market Cap: $2.747M info
MGRX
Nov 12, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.2078
Real-time Price: $0.124 info
Change: -$0.0838 (-40%) info
Market Cap: $2.747M info
MGRX
Nov 06, 2026, 5:25 PM EST
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.190
Real-time Price: $0.124 info
Change: -$0.066 (-35%) info
Market Cap: $2.747M info
MGRX
Oct 09, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.430
Real-time Price: $0.124 info
Change: -$0.306 (-71%) info
Market Cap: $2.747M info